Forecasting The Future: 13 Analyst Projections For Vertex Pharmaceuticals
Forecasting The Future: 13 Analyst Projections For Vertex Pharmaceuticals
預測未來：福泰製藥的13名分析師的預測
In the preceding three months, 13 analysts have released ratings for Vertex Pharmaceuticals (NASDAQ:VRTX), presenting a wide array of perspectives from bullish to bearish.
在過去的三個月中，有13位分析師針對福泰製藥（納斯達克：VRTX）發佈了評級，呈現了從看好到淡漠的廣泛觀點。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析師最近的評級概述，爲了全面了解過去30天的情緒變化並與前幾個月進行比較，提供了深入的見解。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $477.54, a high estimate of $555.00, and a low estimate of $421.00. This current average has increased by 4.91% from the previous average price target of $455.18.
分析師評估的12個月價格目標揭示了更多信息，平均目標爲$ 477.54，最高估值爲$ 555.00，最低估值爲$ 421.00。這個當前平均數比先前的平均價格目標$455.18增加了4.91％。
Exploring Analyst Ratings: An In-Depth...
分析師評級:...
登入免費觀看全文
登入/註冊